Best Neillove podcasts we could find (Updated August 2019)
Related podcasts: Science Cancer Medicine Oncology Researchtopractice  
Neillove public [search 0]
×
Join millions of Player FM users today to get Neillove news and insights whenever you like, even when you're offline. Podcast smarter with the podcast app that refuses to compromise … it's free and easy.
Podcast smarter! Player FM is free and easy.
show episodes
 
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
 
Loading …
show series
 
Visiting Professors: Lung Cancer Edition — Part 1: Our discussion with Drs Levy and Lobins highlights the following topics as well as cases from Dr Lobins’s practice: Case: A man in his early 60s, a current smoker, with metastatic lung adenocarcinoma and a PD-L1 tumor proportion score (TPS) of 80% experiences a dramatic response to first-line p ...…
 
Visiting Professors: Lung Cancer Edition — Part 1: Our discussion with Drs Levy and Lobins highlights the following topics as well as cases from Dr Lobins’s practice: Case: A man in his early 60s, a current smoker, with metastatic lung adenocarcinoma and a PD-L1 tumor proportion score (TPS) of 80% experiences a dramatic response to first-line p ...…
 
Visiting Professors: Lung Cancer Edition — Part 1: Our discussion with Drs Levy and Lobins highlights the following topics as well as cases from Dr Lobins’s practice: Case: A man in his early 60s, a current smoker, with metastatic lung adenocarcinoma and a PD-L1 tumor proportion score (TPS) of 80% experiences a dramatic response to first-line p ...…
 
Visiting Professors: Lung Cancer Edition — Part 1: Our discussion with Drs Levy and Lobins highlights the following topics as well as cases from Dr Lobins’s practice: Case: A man in his early 60s, a current smoker, with metastatic lung adenocarcinoma and a PD-L1 tumor proportion score (TPS) of 80% experiences a dramatic response to first-line p ...…
 
Visiting Professors: Lung Cancer Edition — Part 2: Our discussion with Drs Horn and Ma highlights the following topics as well as cases from Dr Ma’s practice: Case: A woman in her mid-70s with Stage IV lung adenocarcinoma and a PD-L1 TPS of 70% experiences a pathologic fracture of the right femur while receiving first-line pembrolizumab (00:00) ...…
 
Visiting Professors: Lung Cancer Edition — Part 2: Our discussion with Drs Horn and Ma highlights the following topics as well as cases from Dr Ma’s practice: Case: A woman in her mid-70s with Stage IV lung adenocarcinoma and a PD-L1 TPS of 70% experiences a pathologic fracture of the right femur while receiving first-line pembrolizumab (00:00) ...…
 
Visiting Professors: Lung Cancer Edition — Part 2: Our discussion with Drs Horn and Ma highlights the following topics as well as cases from Dr Ma’s practice: Case: A woman in her mid-70s with Stage IV lung adenocarcinoma and a PD-L1 TPS of 70% experiences a pathologic fracture of the right femur while receiving first-line pembrolizumab (00:00) ...…
 
Visiting Professors: Lung Cancer Edition — Part 2: Our discussion with Drs Horn and Ma highlights the following topics as well as cases from Dr Ma’s practice: Case: A woman in her mid-70s with Stage IV lung adenocarcinoma and a PD-L1 TPS of 70% experiences a pathologic fracture of the right femur while receiving first-line pembrolizumab (00:00) ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 1: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Smith’s comments on the application of emerging research to patient care: Appropriate management of mo ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 1: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Smith’s comments on the application of emerging research to patient care: Appropriate management of mo ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 1: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Smith’s comments on the application of emerging research to patient care: Appropriate management of mo ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 1: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Smith’s comments on the application of emerging research to patient care: Appropriate management of mo ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 2: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Raje’s comments on the application of emerging research to patient care: Updated risk-stratification m ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 2: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Raje’s comments on the application of emerging research to patient care: Updated risk-stratification m ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 2: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Raje’s comments on the application of emerging research to patient care: Updated risk-stratification m ...…
 
Meet The Professors: Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma — Part 2: A special video supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring Dr Raje’s comments on the application of emerging research to patient care: Updated risk-stratification m ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Drs Jeremy Abramson, Bruce D Cheson, Ann S LaCasce, Noopur Raje, Paul G Richardson and Sonali M Smith. Introduction Program overview: Dr Love 0m0s Newly Diagnosed and Relapsed/Refractory Multiple Myeloma (MM) — Dr Raje and Dr Richardson Newly Diag ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Drs Jeremy Abramson, Bruce D Cheson, Ann S LaCasce, Noopur Raje, Paul G Richardson and Sonali M Smith. Introduction Program overview: Dr Love 0m0s Newly Diagnosed and Relapsed/Refractory Multiple Myeloma (MM) — Dr Raje and Dr Richardson Newly Diag ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Drs Jeremy Abramson, Bruce D Cheson, Ann S LaCasce, Noopur Raje, Paul G Richardson and Sonali M Smith. Introduction Program overview: Dr Love 0m0s Newly Diagnosed and Relapsed/Refractory Multiple Myeloma (MM) — Dr Raje and Dr Richardson Newly Diag ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Drs Jeremy Abramson, Bruce D Cheson, Ann S LaCasce, Noopur Raje, Paul G Richardson and Sonali M Smith. Introduction Program overview: Dr Love 0m0s Newly Diagnosed and Relapsed/Refractory Multiple Myeloma (MM) — Dr Raje and Dr Richardson Newly Diag ...…
 
A virtual roundtable discussion with noted investigators Dr Toni K Choueiri and Prof Thomas Powles for a review of recent innovations in the treatment of renal cell carcinoma. Risk stratification and selection of first-line therapy for metastatic renal cell carcinoma (mRCC) (00:00) Role of cytoreductive nephrectomy in RCC (1:50) Overall surviva ...…
 
A virtual roundtable discussion with noted investigators Dr Toni K Choueiri and Prof Thomas Powles for a review of recent innovations in the treatment of renal cell carcinoma. Risk stratification and selection of first-line therapy for metastatic renal cell carcinoma (mRCC) (00:00) Role of cytoreductive nephrectomy in RCC (1:50) Overall surviva ...…
 
A virtual roundtable discussion with noted investigators Dr Toni K Choueiri and Prof Thomas Powles for a review of recent innovations in the treatment of renal cell carcinoma. Risk stratification and selection of first-line therapy for metastatic renal cell carcinoma (mRCC) (00:00) Role of cytoreductive nephrectomy in RCC (1:50) Overall surviva ...…
 
A virtual roundtable discussion with noted investigators Dr Toni K Choueiri and Prof Thomas Powles for a review of recent innovations in the treatment of renal cell carcinoma. Risk stratification and selection of first-line therapy for metastatic renal cell carcinoma (mRCC) (00:00) Role of cytoreductive nephrectomy in RCC (1:50) Overall surviva ...…
 
A virtual roundtable discussion with noted investigators Prof Claire Harrison and Dr John Mascarenhas for a review of recent innovations in the treatment of myeloproliferative neoplasms. Biology of myeloproliferative neoplasms (MPN); mutational landscape and implications for prognosis and therapy (00:00) Diagnosis and risk stratification of MPN ...…
 
A virtual roundtable discussion with noted investigators Prof Claire Harrison and Dr John Mascarenhas for a review of recent innovations in the treatment of myeloproliferative neoplasms. Biology of myeloproliferative neoplasms (MPN); mutational landscape and implications for prognosis and therapy (00:00) Diagnosis and risk stratification of MPN ...…
 
A virtual roundtable discussion with noted investigators Prof Claire Harrison and Dr John Mascarenhas for a review of recent innovations in the treatment of myeloproliferative neoplasms. Biology of myeloproliferative neoplasms (MPN); mutational landscape and implications for prognosis and therapy (00:00) Diagnosis and risk stratification of MPN ...…
 
A virtual roundtable discussion with noted investigators Prof Claire Harrison and Dr John Mascarenhas for a review of recent innovations in the treatment of myeloproliferative neoplasms. Biology of myeloproliferative neoplasms (MPN); mutational landscape and implications for prognosis and therapy (00:00) Diagnosis and risk stratification of MPN ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 1: Our interview with Dr Komrokji highlights the following topics and cases from his practice. Approved and emerging therapies for patients with transfusion-dependent myelodysplastic syndromes (MDS); mechanism of action of the investigation ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 1: Our interview with Dr Komrokji highlights the following topics and cases from his practice. Approved and emerging therapies for patients with transfusion-dependent myelodysplastic syndromes (MDS); mechanism of action of the investigation ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 1: Our interview with Dr Komrokji highlights the following topics and cases from his practice. Approved and emerging therapies for patients with transfusion-dependent myelodysplastic syndromes (MDS); mechanism of action of the investigation ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 1: Our interview with Dr Komrokji highlights the following topics and cases from his practice. Approved and emerging therapies for patients with transfusion-dependent myelodysplastic syndromes (MDS); mechanism of action of the investigation ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 2: Our interview with Dr Cappellini highlights the following topics and cases from her practice. Pathophysiology of thalassemia (00:00) Evolution of therapies for thalassemia (4:20) Prevalence and incidence of thalassemia (9:23) Classificat ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 2: Our interview with Dr Cappellini highlights the following topics and cases from her practice. Pathophysiology of thalassemia (00:00) Evolution of therapies for thalassemia (4:20) Prevalence and incidence of thalassemia (9:23) Classificat ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 2: Our interview with Dr Cappellini highlights the following topics and cases from her practice. Pathophysiology of thalassemia (00:00) Evolution of therapies for thalassemia (4:20) Prevalence and incidence of thalassemia (9:23) Classificat ...…
 
Novel and Emerging Therapeutic Strategies in the Management of Hematologic Disorder-Related Anemia — Part 2: Our interview with Dr Cappellini highlights the following topics and cases from her practice. Pathophysiology of thalassemia (00:00) Evolution of therapies for thalassemia (4:20) Prevalence and incidence of thalassemia (9:23) Classificat ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Georgina Long and Drs Jason J Luke and Jeffrey S Weber. Introduction (00:00) Program overview: Dr Love Adjuvant Systemic Therapy of Melanoma (1:33) Case (Dr Weber): A man in his early 50s with melanoma and a BRAF V600E tumor mutation who rece ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Georgina Long and Drs Jason J Luke and Jeffrey S Weber. Introduction (00:00) Program overview: Dr Love Adjuvant Systemic Therapy of Melanoma (1:33) Case (Dr Weber): A man in his early 50s with melanoma and a BRAF V600E tumor mutation who rece ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Georgina Long and Drs Jason J Luke and Jeffrey S Weber. Introduction (00:00) Program overview: Dr Love Adjuvant Systemic Therapy of Melanoma (1:33) Case (Dr Weber): A man in his early 50s with melanoma and a BRAF V600E tumor mutation who rece ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Georgina Long and Drs Jason J Luke and Jeffrey S Weber. Introduction (00:00) Program overview: Dr Love Adjuvant Systemic Therapy of Melanoma (1:33) Case (Dr Weber): A man in his early 50s with melanoma and a BRAF V600E tumor mutation who rece ...…
 
A presentation from Dr O’Shaughnessy featuring emerging research and cases from her practice. Introduction (00:00) Program overview: Dr Love Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment (1:20) Case: A woman in her early 60s with ER/PR-positive, HER2-negative breast cancer (BC) who experienced intolerable arthralgias ...…
 
A presentation from Dr O’Shaughnessy featuring emerging research and cases from her practice. Introduction (00:00) Program overview: Dr Love Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment (1:20) Case: A woman in her early 60s with ER/PR-positive, HER2-negative breast cancer (BC) who experienced intolerable arthralgias ...…
 
A presentation from Dr O’Shaughnessy featuring emerging research and cases from her practice. Introduction (00:00) Program overview: Dr Love Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment (1:20) Case: A woman in her early 60s with ER/PR-positive, HER2-negative breast cancer (BC) who experienced intolerable arthralgias ...…
 
A presentation from Dr O’Shaughnessy featuring emerging research and cases from her practice. Introduction (00:00) Program overview: Dr Love Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment (1:20) Case: A woman in her early 60s with ER/PR-positive, HER2-negative breast cancer (BC) who experienced intolerable arthralgias ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Dirk Arnold and Drs Tanios Bekaii-Saab, Joseph Chao, Anthony El-Khoueiry, Richard S Finn, Yelena Y Janjigian, Scott Kopetz and Eileen M O’Reilly. Introduction (00:00) Program overview: Dr Love Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry a ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Dirk Arnold and Drs Tanios Bekaii-Saab, Joseph Chao, Anthony El-Khoueiry, Richard S Finn, Yelena Y Janjigian, Scott Kopetz and Eileen M O’Reilly. Introduction (00:00) Program overview: Dr Love Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry a ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Dirk Arnold and Drs Tanios Bekaii-Saab, Joseph Chao, Anthony El-Khoueiry, Richard S Finn, Yelena Y Janjigian, Scott Kopetz and Eileen M O’Reilly. Introduction (00:00) Program overview: Dr Love Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry a ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Dirk Arnold and Drs Tanios Bekaii-Saab, Joseph Chao, Anthony El-Khoueiry, Richard S Finn, Yelena Y Janjigian, Scott Kopetz and Eileen M O’Reilly. Introduction (00:00) Program overview: Dr Love Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry a ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Jonathan A Ledermann and Drs Joyce F Liu and David M O’Malley. Introduction Program overview: Dr Love (00:00) Genetic Drivers of Ovarian Cancer Development and Current Testing Algorithms; PARP Inhibitors in the Management of Newly Diagnosed D ...…
 
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Jonathan A Ledermann and Drs Joyce F Liu and David M O’Malley. Introduction Program overview: Dr Love (00:00) Genetic Drivers of Ovarian Cancer Development and Current Testing Algorithms; PARP Inhibitors in the Management of Newly Diagnosed D ...…
 
Google login Twitter login Classic login